1 | with a focus on | | | | | | | 2 | 0.89% |
2 | © 2024 akina inc | | | | | | | 1 | 0.44% |
3 | open for collaboration learn | | | | | | | 1 | 0.44% |
4 | development projects housed under | | | | | | | 1 | 0.44% |
5 | projects housed under the | | | | | | | 1 | 0.44% |
6 | housed under the polyscitech | | | | | | | 1 | 0.44% |
7 | under the polyscitech division | | | | | | | 1 | 0.44% |
8 | the polyscitech division which | | | | | | | 1 | 0.44% |
9 | are open for collaboration | | | | | | | 1 | 0.44% |
10 | for collaboration learn more | | | | | | | 1 | 0.44% |
11 | has several inhouse research | | | | | | | 1 | 0.44% |
12 | collaboration learn more about | | | | | | | 1 | 0.44% |
13 | learn more about the | | | | | | | 1 | 0.44% |
14 | more about the products | | | | | | | 1 | 0.44% |
15 | about the products and | | | | | | | 1 | 0.44% |
16 | the products and research | | | | | | | 1 | 0.44% |
17 | leveraging the developed experience | | | | | | | 1 | 0.44% |
18 | and development projects housed | | | | | | | 1 | 0.44% |
19 | akina inc has several | | | | | | | 1 | 0.44% |
20 | developed experience with synthesis | | | | | | | 1 | 0.44% |
21 | polymers fluorescent products chemical | | | | | | | 1 | 0.44% |
22 | providing research reagents and | | | | | | | 1 | 0.44% |
23 | products with a focus | | | | | | | 1 | 0.44% |
24 | a focus on biomedical | | | | | | | 1 | 0.44% |
25 | focus on biomedical applications | | | | | | | 1 | 0.44% |
26 | on biomedical applications this | | | | | | | 1 | 0.44% |
27 | biomedical applications this includes | | | | | | | 1 | 0.44% |
28 | biodegradablebiocompatible polymers fluorescent products | | | | | | | 1 | 0.44% |
29 | intermediates assay kits and | | | | | | | 1 | 0.44% |
30 | additionally akina inc has | | | | | | | 1 | 0.44% |
31 | assay kits and other | | | | | | | 1 | 0.44% |
32 | kits and other products | | | | | | | 1 | 0.44% |
33 | and other products used | | | | | | | 1 | 0.44% |
34 | other products used in | | | | | | | 1 | 0.44% |
35 | products used in research | | | | | | | 1 | 0.44% |
36 | used in research and | | | | | | | 1 | 0.44% |
37 | development additionally akina inc | | | | | | | 1 | 0.44% |
38 | the developed experience with | | | | | | | 1 | 0.44% |
39 | experience with synthesis and | | | | | | | 1 | 0.44% |
40 | focuses on providing research | | | | | | | 1 | 0.44% |